Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Neurocrine Biosciences CSO Reports PRSU Vesting Transaction

Jude Onyia, Chief Scientific Officer of Neurocrine Biosciences Inc., filed a Form 4 with the SEC on September 15, 2026, disclosing changes in beneficial ownership of common stock stemming from the vesting of performance restricted stock units on September 11, 2026.

Aakashdeep | 15 September 2026

Neurocrine Biosciences CMO Reports PRSU Vesting Transaction

Sanjay Chandru Keswani, Chief Medical Officer of Neurocrine Biosciences Inc. (NASDAQ:NBIX), filed a Form 4 on September 15, 2026, disclosing changes in beneficial ownership of common stock stemming from the vesting of performance restricted stock units on September 11, 2026.

Manish Choudhary | 15 September 2026

Neurocrine Biosciences CLO Reports PRSU Vesting

Darin Lippoldt, Chief Legal Officer of Neurocrine Biosciences Inc., filed a Form 4 on September 15, 2026, disclosing the vesting of performance restricted stock units and a related tax withholding transaction dated September 11, 2026.

Vinay Lochav | 15 September 2026

Impinj CEO Chris Diorio Disposes of 10,000 Shares

A Form 4 filed on September 15, 2026 reports that Chris Diorio, Ph.D., Chief Executive Officer and Director of Impinj Inc, disposed of 10,000 shares of common stock on September 14, 2026 under a Rule 10b5-1 trading plan.

Manish Choudhary | 15 September 2026

Immunome Chief Scientific Officer Files Form 4 on Stock Activity

Jack Higgins, Chief Scientific Officer of Immunome Inc. (NASDAQ:IMNM), filed a Form 4 on September 15, 2026, reporting multiple transactions in common stock and employee stock options dated September 11, 2026.

Aakashdeep | 15 September 2026

Colgate-Palmolive CFO Reports Share Withholding Transactions

Stanley J. Sutula III, Chief Financial Officer of Colgate-Palmolive Co, filed a Form 4 on September 15, 2026, disclosing three share withholding transactions on common stock tied to the vesting of restricted stock units between September 11 and September 13, 2026.

Aditi Sarkar | 15 September 2026

Wealthfront Corp CEO David Fortunato Files Form 4

David Fortunato, CEO and President of Wealthfront Corp (NASDAQ:WLTH), filed a Form 4 on September 15, 2026, disclosing option exercises and a share disposition by his spouse on September 11, 2026.

Aditi Sarkar | 15 September 2026

Liquidia Corp Director Reports Option Exercises and Stock Sales

Raman Singh, a director of Liquidia Corp, filed a Form 4 on September 15, 2026, disclosing the exercise of non-qualified stock options and subsequent sales of common stock on September 11 and September 14, 2026.

Vinay Lochav | 15 September 2026

Honest Company SVP Sells 25,000 Shares of Common Stock

Thomas Sternweis, SVP of Enterprise Development and Strategy at The Honest Company, Inc. (NASDAQ:HNST), filed a Form 4 on September 15, 2026, disclosing the sale of 25,000 shares of common stock on September 14, 2026.

Anjali Anand | 15 September 2026

Datadog CPO Li Yanbing Sells 12,700 Shares in September 2026

A Form 4 filed on September 15, 2026, with the U.S. Securities and Exchange Commission discloses that Li Yanbing, Chief Product Officer of Datadog, Inc. (NASDAQ:DDOG), sold 12,700 shares of Class A Common Stock on September 11, 2026, pursuant to a pre-established 10b5-1 trading …

Shwetambri Chauhan | 15 September 2026
Support

Hi! How can we help you today?

Loading…